Arabian International Healthcare Holding Co. (Tibbiyah) posted an 86% leap in 2023 net profit to SAR 38.1 million, compared to SAR 20.5 million a year earlier.
| Item | 2022 | 2023 | Change |
|---|---|---|---|
| Revenues | 642.67 | 806.92 | 25.6 % |
| Gross Income | 154.16 | 190.04 | 23.3 % |
| Operating Income | 44.03 | 46.72 | 6.1 % |
| Net Income | 20.47 | 38.09 | 86.0 % |
| Average Shares | 20.00 | 20.00 | - |
| EPS (Riyals) | 1.02 | 1.90 | 86.0 % |
The company recorded revenue of SAR 806.9 million in 2023, an increase of 25.6% year-on-year (YoY) from SAR 642.7 million. This was driven by a strong core growth on the robust performance of subsidiary Al Faisaliah Medical Systems (FMS) and the continued reliability of International Medical Supplies (Premma). This was supported by the positive contribution of Innovative Healthcare Company Holding Limited (IHC).
FMS registered a 37.4% increase YoY in revenue on the back of a solid project backlog with a healthy order intake, increased private sector demand and addition of new suppliers.
Although Premma faced a challenging first half of the year, it registered a positive performance overall, demonstrating the resilience and strength of its fundamentals.
Shareholders' equity, no minority interest, reached SAR 306.59 million at the end of 2023, up from SAR 289.67 million in 2022.
|
Historical Data |
|||
|
Period |
Revenues (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
|
H1 2020 |
193.65 |
(30.96) |
(1.55) |
|
H2 2020 |
625.04 |
126.75 |
6.34 |
|
H1 2021 |
249.24 |
5.10 |
0.25 |
|
H2 2021 |
369.30 |
77.21 |
3.86 |
|
H1 2022 |
215.24 |
(20.68) |
(1.03) |
|
H2 2022 |
427.43 |
41.15 |
2.06 |
|
H1 2023 |
315.96 |
(80.22) |
(14.1) |
|
H2 2023 |
490.96 |
60.89 |
3.04 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}